Health Care Supplies

Sharps Tech

Sharps Tech released FY2025 Q3 earnings on November 14 (EST), actual revenue USD 2.289 M (forecast USD 350 K), actual EPS USD -4.33 (forecast USD -1.01)

Sharps Tech released FY2025 9-month earnings on November 14 (EST), actual revenue USD 306.34K, actual EPS USD 37.8736

Sharps Technology Inc. Announces Stock Repurchase Program and Expands Digital Asset Holdings

Sharps Technology Inc. Announces $100 Million Stock Repurchase and Partners with Crypto.com

Sharps Technology Partners with Jupiter to Stake SOL for Enhanced Solana Adoption

Sharps Technology Partners with BONK to Stake SOL and Enhance Solana Ecosystem Liquidity

Pudgy Penguins and Sharps Technology Partner to Advance Solana NFT Institutional Adoption

Sharps Technology Inc. Announces Major Expansion Through Acquisition of Solana

Sharps Technology Inc. Expands Digital Asset Portfolio Through SOL Token Acquisition

Sol Mining Launches SOL Mining Contract to Simplify Blockchain Mining

Sharps Technology Inc. completes private placement and plans to acquire SOL

Sharps Tech released FY2025 Q2 earnings on August 13 (EST), actual revenue USD 222.72 K (forecast USD 250 K), actual EPS USD 3.5764 (forecast USD -0.94)

Sharps Tech released FY2025 Semi-Annual earnings on August 13 (EST), actual revenue USD 222.72K, actual EPS USD 10.4499

STSS Announces Second $50 Million Syringe Shipment

Sharps Technology CEO to Speak Online on June 12

Sharps Technology CEO to Speak at Virtual Summit and Announce First Commercial Shipment

Sharps Tech released FY2025 Q1 earnings on May 15 (EST), actual revenue USD 0, actual EPS USD 38.6245

Sharps Technology Inc. Submits Beneficial Ownership Statement

Sharps Technology Receives Order for 500 Million Syringes

Sharps Tech released FY2024 annual earnings on March 27 (EST), actual revenue USD 0 (forecast USD 32.38 M), actual EPS USD 0 (forecast USD -990.0108)

A SPAC III Acquisition

PicoCELA

Davis Commodities

Society Pass

ECD Automotive Design

Gauzy

Bristol-Myers Squibb Company

A SPAC III ACQUISITION CORP. COM NPV CL A (SUBS/RTS)02/01/2026

Paranovus ENT Tech

Cue BioPharma

Essilor

HOYA Corporation

Merit Medical

UFP Tech

Acme Utd

Xtant Med

STANDARD DENTAL LABS INC

Alcon

Cooper Cos

Solventum

Style Score

Growth Score

Revenue YoY

Net Profit YoY

Value Score

P/B Ratio

Dividend Ratio

Size Score

Market Cap Score

Market Cap

Revenue Score

Revenue

Multi Score

Profit Score

Profit Margin

Gross Margin

Total Assets YoY

Net Assets YoY

Cash Score

Cash Flow Margin

OCF YoY

Operating Score

Turnover

Debt Score

Gearing Ratio

Please note that a "Suspected value trap" is a stock that appears The stock looks financially sound and severely undervalued, but behind the low valuation is a long-term decline in business capacity or a serious financial crisis, or even the risk of bankruptcy in the short term.

Suspected value trap